why choose us

First received: May 31, 2024

Clinical Trial: Lebrikizumab Pen Ease of Use in Participants With Atopic Dermatitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: Study to Assess Lebrikizumab Pen Ease of Use in Patients With Atopic Dermatitis

Brief Summary: The purpose of this study is to assess the ease of use of the lebrikizumab pen.Participants will use a practice pad to simulate administration of a dose.Participants will complete the modified Subcutaneous Administration Assessment Questionnaire (mSQAAQ) following the simulated injection.This study involves one study visit.

Read more